-+ 0.00%
-+ 0.00%
-+ 0.00%

Immunocore Announces 2026 Plans to Expand KIMMTRAK Access, Complete Phase 3 Melanoma Trials, Advance PRAME Franchise, and Initiate New Autoimmune and HIV Studies

Reuters·01/09/2026 12:13:34

Please log in to view news